-
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
J Virol. 2002 Jul;76(13):6780-90
PMID: 12050391
-
Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.
J Virol. 2002 Mar;76(6):2683-91
PMID: 11861835
-
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54
PMID: 12444251
-
Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors.
J Virol. 2003 Jan;77(2):1610-3
PMID: 12502877
-
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.
Mol Biol Cell. 2003 Mar;14(3):926-38
PMID: 12631714
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions.
J Virol. 2003 May;77(10):5678-84
PMID: 12719560
-
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
J Virol. 2003 May;77(10):5829-36
PMID: 12719576
-
Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein.
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5016-21
PMID: 12702763
-
Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion.
J Virol. 2003 Jun;77(12):7067-77
PMID: 12768026
-
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.
Antiviral Res. 2003 Jul;59(2):137-42
PMID: 12895697
-
Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
J Virol. 2004 Jan;78(2):1026-31
PMID: 14694135
-
The 447-52D antibody: hitting HIV-1 where its armor is thickest.
Structure. 2004 Feb;12(2):173-4
PMID: 14962377
-
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Structure. 2004 Feb;12(2):193-204
PMID: 14962380
-
Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.
J Virol. 2004 May;78(10):5500-6
PMID: 15113929
-
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
J Mol Biol. 2004 Jun 25;340(1):9-14
PMID: 15184018
-
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
Cell. 1986 Nov 7;47(3):333-48
PMID: 3094962
-
Active human immunodeficiency virus protease is required for viral infectivity.
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90
PMID: 3290901
-
Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.
J Virol. 1989 Jun;63(6):2550-6
PMID: 2657099
-
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5
PMID: 2788277
-
The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.
J Virol. 1989 Oct;63(10):4395-403
PMID: 2778881
-
SIV adaptation to human cells.
Nature. 1989 Oct 19;341(6243):573-4
PMID: 2677749
-
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10134-7
PMID: 1719545
-
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
Gene. 1991 Dec 15;108(2):193-9
PMID: 1660837
-
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.
J Virol. 1992 Dec;66(12):7538-42
PMID: 1433529
-
Atomic structure of the ectodomain from HIV-1 gp41.
Nature. 1997 May 22;387(6631):426-30
PMID: 9163431
-
Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay.
Cytometry. 2002 Feb 1;47(2):100-6
PMID: 11813199
-
Mechanisms of viral membrane fusion and its inhibition.
Annu Rev Biochem. 2001;70:777-810
PMID: 11395423
-
Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion.
J Virol. 2002 Apr;76(7):3522-33
PMID: 11884576
-
A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
AIDS Res Hum Retroviruses. 1993 Jan;9(1):23-32
PMID: 8094000
-
Detection and quantitation of cell-cell electrofusion products by flow cytometry.
Anal Biochem. 1994 Feb 1;216(2):271-5
PMID: 7513970
-
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.
Biochemistry. 1995 Nov 21;34(46):14955-62
PMID: 7578108
-
The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion.
J Virol. 1997 Feb;71(2):1453-65
PMID: 8995671
-
Core structure of gp41 from the HIV envelope glycoprotein.
Cell. 1997 Apr 18;89(2):263-73
PMID: 9108481
-
Expression cloning of new receptors used by simian and human immunodeficiency viruses.
Nature. 1997 Jul 17;388(6639):296-300
PMID: 9230441
-
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.
J Virol. 1997 Sep;71(9):7136-9
PMID: 9261451
-
Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
J Virol. 1999 Dec;73(12):10310-9
PMID: 10559349
-
Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.
J Clin Microbiol. 2000 Aug;38(8):3055-60
PMID: 10921977
-
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
J Virol. 2000 Sep;74(18):8358-67
PMID: 10954535
-
Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.
J Virol. 2000 Oct;74(20):9381-7
PMID: 11000206
-
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
J Cell Biol. 2000 Oct 16;151(2):413-23
PMID: 11038187
-
Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection.
Virology. 2000 Oct 25;276(2):229-37
PMID: 11040114
-
Protein design of an HIV-1 entry inhibitor.
Science. 2001 Feb 2;291(5505):884-8
PMID: 11229405
-
Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
J Virol. 2001 Jun;75(11):5230-9
PMID: 11333905
-
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion.
EMBO J. 2001 Aug 1;20(15):4024-34
PMID: 11483506
-
Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
J Virol. 2001 Sep;75(18):8605-14
PMID: 11507206
-
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92
PMID: 11572974
-
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
Biochemistry. 2001 Oct 16;40(41):12231-6
PMID: 11591141
-
Atomic structure of a thermostable subdomain of HIV-1 gp41.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12303-8
PMID: 9356444
-
Capture of an early fusion-active conformation of HIV-1 gp41.
Nat Struct Biol. 1998 Apr;5(4):276-9
PMID: 9546217
-
A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.
J Biol Chem. 1998 Jun 19;273(25):15773-8
PMID: 9624176
-
HIV entry and its inhibition.
Cell. 1998 May 29;93(5):681-4
PMID: 9630213
-
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9134-9
PMID: 9689046
-
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
Nat Med. 1998 Nov;4(11):1302-7
PMID: 9809555
-
HIV-1 envelope determinants for cell tropism and chemokine receptor use.
Mol Membr Biol. 1999 Jan-Mar;16(1):57-65
PMID: 10332738
-
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6359-64
PMID: 10339592
-
Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.
J Virol. 1999 Oct;73(10):8216-26
PMID: 10482572
-
CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.
J Virol. 2001 Nov;75(22):10766-78
PMID: 11602718
-
The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain.
Virology. 2002 Oct 10;302(1):174-84
PMID: 12429526